BDBM238870 US10052306, 309::rac-2-((3aR,6aS)-5- benzylhexahydrocyclo- penta[c]pyrrol-2(1H)- yl)-1-(3- (trifluoromethyl)phenyl) ethanol

SMILES OC(CN1C[C@@H]2CC(Cc3ccccc3)C[C@@H]2C1)c1cccc(c1)C(F)(F)F

InChI Key InChIKey=HCAYVSOIBABBCF-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 238870   

TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Cadent Therapeutics

US Patent
LigandPNGBDBM238870(rac-2-((3aR,6aS)-5- benzylhexahydrocyclo- penta[c]...)
Affinity DataIC50: 1.00E+4nMAssay Description:To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
US Patent